Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The "tripartite motif containing 13 pseudogene" is a genomic DNA region that shares sequence similarity with the protein-coding TRIM13 gene but is classified as a *pseudogene*, meaning it does not encode a functional protein.[3][1] Pseudogenes typically arise through gene duplication or retrotransposition, and while they may be transcribed in some cases, they are not generally considered therapeutic targets. For functional reference, TRIM13 is an E3 ubiquitin ligase involved in protein degradation, stress response, apoptosis, and immune signaling[3].\n\nIn summary, ENSG00000262140 identifies a pseudogene, which is not a functional or druggable target, and is therefore not generally relevant for therapeutic targeting. The *functional gene* TRIM13, by contrast, encodes a ubiquitin ligase implicated in protein homeostasis and disease, and is the subject of biomedical research.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tripartite motif containing 13 pseudogene.